跳至主要内容
临床试验/CTRI/2020/05/025430
CTRI/2020/05/025430尚未招募1 期

A Cross Sectional Study To Observe The Health Status Of Personnels Engaged In Care Of Covid-19 Infected/Suspected Persons And Receiving Ayurveda Immuno-Modulator Drugs In Jodhpur City

Dabur India Ltd1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年3月6日最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
1,000
试验地点
1
主要终点
To boost immunity of engaged person in care of COVID-19 infected/ suscpected cases

研究概览

简要总结

On 12 January 2020, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan City, Hubei Province, China, which was reported to the WHO on 31 December 2019. On 30 January, India reported its first case of COVID-19 in Kerala. The transmission escalated during March, after several cases were reported all over the country, most of which were linked to people with a travel history to affected countries. On 24 March, PM announced a complete nationwide lockdown, starting from midnight for 21 days.

 In Rajasthan, on 2 March 2020, an Italian tourist who was part of a group of 23 tourists from Italy tested positive for COVID-19. The first case in Jodhpur was reported in second week of March, 2020 Jodhpur with a population of 9.21 lakh. Local administration worked very efficiently and established several Quarantine Centres in the city to admit all the suspected contacts of confirmed cases. A big number of Medical including AYUSH doctors, para-medical, housekeeping, security/ police staff and other supporting staff are serving continuously and are having great risk of infection. However, susceptibility of infection is much concerned with individual immunity status. A person with good immunity is likely to be affected less.

 Ministry of AYUSH, Govt of India has issued an Advisory and suggested various measures including use of certain Ayurvedic medicines which are quite effective to modulate the immune system to keep the status of immunity at optimum level. On demand of local administration, the University has arranged such drugs for those personals and they started using them as per directions of concerned experts. Taking this opportunity in action, a research group formed through Centre for Innovation & Research Network, DSRR Ayurved University, Jodhpur, has planned to conduct a cross-sectional study to observe that whether the persons taking Ayurveda immune-modulators are having any impact on their health status.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Person deployed in quarentine ward Person on hard duty family members of health care personnel willingness to participate in study Taking Ayurveda immunomodulator drugs ( Tab.
  • Maha Sudarshan vati + Tab Samshamani Vati + Tab.

排除标准

  • Person below 18 yrs & above 65 yrs Preganant women Any medical condition for which the person is recieing any immunosupressive medicine Known case of malignancy.

结局指标

主要结局

To boost immunity of engaged person in care of COVID-19 infected/ suscpected cases

时间窗: 15 days

次要结局

  • To maintain healthy status of engaged person in care of COVID-19 infected/ suscpected cases-15 days(15 DAYS)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验

EFFECT OF AYURVEDA IMMUNO-MODULATOR DRUGS on HEALTH... | 临床试验